Adcock Ingram, Cipla awarded portions of State’s ARV tender

18th February 2019

By: Tasneem Bulbulia

Senior Contributing Editor Online

     

Font size: - +

Pharmaceutical manufacturers Adcock Ingram and Cipla have each secured a portion of a tender to provide State-run hospitals with antiretroviral (ARV) medicines over a three-year period from July 1.

Adcock was awarded a 12% share of the ARV tender.  

The company had submitted bids for the triple combination products, tenofovir/emtricitabine/efavirenz (TEE) and dolutegravir/lamivudine/tenofovir (DLT), as well as a number of the dual and monotherapy molecules.

Adcock’s share of the ARV tender award over the three years includes 11%, or 16.8-million, of the 147-million packs of DLT sought through the tender, 2.8-million packs of other oral solid dosage products and 2.7-million bottles of oral solutions.

The company indicated that its investment into its oral solid dosage facility, in Wadeville, Gauteng, has increased its ability to manufacture and supply ARV medicines to the public sector through the tender system, and also meet the needs of the private healthcare market.

Meanwhile, Cipla on Monday said it too had been awarded a share of the ARV tender for TEE and DLT.  

Cipla recently launched a new triple-combination ARV treatment, Reydin, that comprises tenofovir, lamivudine and dolutegravir, adding to its comprehensive portfolio of HIV medication.

Edited by Chanel de Bruyn
Creamer Media Senior Deputy Editor Online

Comments

The content you are trying to access is only available to subscribers.

If you are already a subscriber, you can Login Here.

If you are not a subscriber, you can subscribe now, by selecting one of the below options.

For more information or assistance, please contact us at subscriptions@creamermedia.co.za.

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION